Need Help? Call 1­-866-­796-­7386
« back to stock screener

  HALO stock: Halozyme Therapeutics, Inc.

Current Rating
Buy

Previous Rating

Strong Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$46.90
Market Cap
6.34B
Sector
Health Care
Div. Growth
-
P/E
15.2
P/B
24.01
P/S
13.25
Dividend %
-
P/CF
-
P/FCF
22.9
Op. Cash Flow
288.9K
FCF
1.9
Op. Margin
63.80%
Net Margin
92.20%
ROE
202.60%
ROI
38.10%
ROA
38.90%
EPS Growth
156.90%
Current Ratio
7.9
Debt/Equity
399.60%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Biostem Technologies Inc (BSEM) $1.95 - - 22M Strong Buy
Lannett Company, Inc. (LCI) $0.58 - - 22.4M Strong Buy
Clearside Biomedical Inc (CLSD) $1.65 - - 78.2M Strong Buy
Assertio Holdings Inc (ASRT) $2.73 - - 136.8M Strong Buy
Arbutus Biopharma Corp (ABUS) $2.84 - - 361.4M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More